Relationship Between Polyunsaturated Fatty Acid and Eating Disorders: Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Objectives: Eating disorders result in poor nutrition, poor physical conditions and even suicidality and mortality. Although polyunsaturated fatty acids (PUFAs) have attracted attention in the emerging field of nutritional psychiatry, their role in eating disorders remains unknown. This meta-analysis investigates the differences of PUFA levels between patients with eating disorders and healthy controls, and the potentially beneficial effects of PUFAs in such patients.
Methods: We conducted a systematic literature search and meta-analysis under the random effects model.
Result: Eleven studies were included in the current meta-analysis. Compared with controls, 379 patients with eating disorders had significantly higher plasma levels of alpha-linolenic acid, eicosapentaenoic acid, stearidonic acid, osbond acid, palmitoleic acid, oleic acid, and total omega-3 fatty acids; and lower levels of total omega-6 fatty acids and omega-6/omega-3 ratio. Eating disorders were associated with significantly higher red blood cell membrane levels of palmitoleic acid and oleic acid and lower levels of adrenic acid, arachidonic acid, and total omega-6 fatty acids. In addition, PUFA supplements were associated with a benefit to body weight outcomes but not disease severity and mood symptoms in interventional trials.
Discussion: This meta-analysis indicates abnormal levels of PUFAs in peripheral blood tissues in patients with eating disorders. The relationship between PUFAs and eating disorders should be interpreted cautiously considering the specific lipid metabolism under starvation state. To investigate the role of PUFAs on psychopathological and therapeutic effects in eating disorders, further larger clinical studies are warranted.
Fatty Acids and Their Lipogenic Enzymes in Anorexia Nervosa Clinical Subtypes.
Nguyen N, Woodside D, Lam E, Quehenberger O, German J, Shih P Int J Mol Sci. 2024; 25(10).
PMID: 38791555 PMC: 11122126. DOI: 10.3390/ijms25105516.
Sasanfar B, Toorang F, Salehi-Abarghouei A Syst Rev. 2024; 13(1):44.
PMID: 38281014 PMC: 10821539. DOI: 10.1186/s13643-023-02430-y.
Effectiveness of dietary interventions in mental health treatment: A rapid review of reviews.
Burrows T, Teasdale S, Rocks T, Whatnall M, Schindlmayr J, Plain J Nutr Diet. 2022; 79(3):279-290.
PMID: 35796181 PMC: 9545734. DOI: 10.1111/1747-0080.12754.
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Ragnhildstveit A, Slayton M, Jackson L, Brendle M, Ahuja S, Holle W Brain Sci. 2022; 12(3).
PMID: 35326338 PMC: 8963252. DOI: 10.3390/brainsci12030382.
The Gut Microbiome and Metabolomics Profiles of Restricting and Binge-Purging Type Anorexia Nervosa.
Monteleone A, Troisi J, Serena G, Fasano A, Dalle Grave R, Cascino G Nutrients. 2021; 13(2).
PMID: 33557302 PMC: 7915851. DOI: 10.3390/nu13020507.